Improvement in hepatic fibrosis is seen in HCV patients who relapse or do not respond to PEG-IFN A2B (PEG-intron).KL Lindsay,C Trepo, ZD Goodman,JK AlbrechtHEPATOLOGY（2000）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
